Document is current
Any future updates will be listed below
-
Authors
Chwalenia, Katarzyna
Feng, Vivi-Yun
Hemmer, Nicole
Friedrichsen, Hans J.
Vorobieva, Ioulia
Wood, Matthew J. A. https://orcid.org/0000-0002-5436-6011
Roberts, Thomas C. https://orcid.org/0000-0002-3313-7631
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council
- License Information
-
More Information
Article History
Received: 17 March 2025
Revised: 22 July 2025
Accepted: 5 August 2025
First Online: 15 August 2025
Competing interests
: MJAW is an advisor and shareholder in PepGen Ltd, a biotechnology company that aims to generate exon skipping therapies for DMD. The remaining authors declare no competing financial interests.
